Track topics on Twitter Track topics that are important to you
A clinical trial led by Imperial College London has revealed the potential of a risky new therapy to stop the progression of multiple sclerosis. Worldwide, there are 2.3 million people with multiple sclerosis (MS), a disease caused by a defective ...
This awesome article Resetting the Immune System to Stop Multiple Sclerosis appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)
Original Article: Resetting the Immune System to Stop Multiple SclerosisNEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Multiple Sclerosis MS
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference in nerve signaling. Symptoms experienced depend on the pa...